MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 185 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4 | -99.9% | 129 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | -20.0% | 129 | -18.9% | 0.00% | – |
Q2 2022 | $5,000 | +25.0% | 159 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -71.4% | 159 | -73.8% | 0.00% | – |
Q2 2020 | $14,000 | -97.5% | 606 | -99.0% | 0.00% | -100.0% |
Q4 2019 | $566,000 | -52.8% | 57,900 | -54.2% | 0.00% | -50.0% |
Q3 2019 | $1,200,000 | +80.7% | 126,500 | +126.3% | 0.00% | +100.0% |
Q2 2019 | $664,000 | -67.7% | 55,900 | -52.1% | 0.00% | -75.0% |
Q1 2019 | $2,055,000 | +41.0% | 116,700 | +39.1% | 0.01% | +33.3% |
Q4 2018 | $1,457,000 | +53.2% | 83,900 | +31.5% | 0.01% | +50.0% |
Q3 2018 | $951,000 | -6.2% | 63,800 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,014,000 | +11.9% | 63,800 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $906,000 | +235.6% | 63,800 | +230.6% | 0.00% | +300.0% |
Q4 2017 | $270,000 | -80.6% | 19,300 | -75.5% | 0.00% | -83.3% |
Q4 2016 | $1,395,000 | +4.8% | 78,800 | +14.2% | 0.01% | -14.3% |
Q3 2016 | $1,331,000 | – | 69,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acuitas Investments, LLC | 283,983 | $6,299,000 | 3.15% |
Euclidean Technologies Management, LLC | 128,088 | $2,841,000 | 2.26% |
GLOBEFLEX CAPITAL L P | 185,939 | $4,124,000 | 0.74% |
HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,194,000 | 0.66% |
CLARK ESTATES INC/NY | 220,000 | $4,880,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,424,274 | $31,590,000 | 0.56% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 789,827 | $17,518,000 | 0.53% |
EARNEST PARTNERS LLC | 3,885,748 | $86,186,000 | 0.51% |
MOODY ALDRICH PARTNERS LLC | 137,075 | $3,040,000 | 0.43% |
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 414,323 | $9,190,000 | 0.33% |